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Abstract
The mechanisms by which noninvasive vagal nerve stimulation (nVNS) affect central and
peripheral neural circuits that subserve pain and autonomic physiology are not clear, and
thus remain an area of intense investigation. Effects of nVNS vs sham stimulation on subject
responses to five noxious thermal stimuli (applied to left lower extremity), were measured in
30 healthy subjects (n = 15 sham and n = 15 nVNS), with fMRI and physiological galvanic
skin response (GSR). With repeated noxious thermal stimuli a group × time analysis showed
a significantly (p < .001) decreased response with nVNS in bilateral primary and secondary
somatosensory cortices (SI and SII), left dorsoposterior insular cortex, bilateral paracentral
lobule, bilateral medial dorsal thalamus, right anterior cingulate cortex, and right orbitofrontal
cortex. A group × time ×GSR analysis showed a significantly decreased response in the
nVNS group (p < .0005) bilaterally in SI, lower and mid medullary brainstem, and inferior
occipital cortex. Finally, nVNS treatment showed decreased activity in pronociceptive brain-
stem nuclei (e.g. the reticular nucleus and rostral ventromedial medulla) and key autonomic
integration nuclei (e.g. the rostroventrolateral medulla, nucleus ambiguous, and dorsal
motor nucleus of the vagus nerve). In aggregate, noninvasive vagal nerve stimulation
reduced the physiological response to noxious thermal stimuli and impacted neural circuits
important for pain processing and autonomic output.
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Introduction
Noninvasive vagus nerve stimulation
Afferent and efferent vagus nerve signaling are critical mediators of physiological homeostasis,
modulating heart rate, gastrointestinal tract motility and secretion, pancreatic endocrine and
exocrine secretion, hepatic glucose production, and other skeletal and visceral functions that
together make the vagus nerve the principle nerve of the parasympathetic nervous system [1].
Vagal fibers can be activated with exogenous electrical stimulation carried out with surgically
implanted vagus nerve stimulation (sVNS) devices (implanted around the vagus nerve in the
carotid sheath). Surgically implanted vagus nerve stimulation is approved by the United States
Food and Drug Administration (FDA) for the treatment of epilepsy [2] and for treatment-
resistant major depression (TRMD); [3–5]. However, cervical sVNS can result in complica-
tions, including hoarseness, dyspnea, nausea, and postoperative pain [6, 7].
Noninvasive techniques for VNS have beneficial effects in treating epilepsy, depression,
and pain. Treatment includes the use of devices that activate the auricular branch (termed
Arnold’s nerve) of the vagus nerve [8–10] and the cervical vagus nerve (found within the
carotid sheath) [11]. Cervical transcutaneous noninvasive vagus nerve stimulation (nVNS)
has shown promising therapeutic effects in the treatment of acute and chronic migraine
headaches [12–14], and acute and chronic cluster headaches [15], and is now FDA-
approved to treat both episodic cluster [14] and acute migraine headaches [7, 16, 17].
Recent work has shown that, with finite element modeling of cervical nVNS, the electrical
field significantly penetrates the human neck and is sufficient to activate the cervical vagus
nerve [11]. Moreover cervical nVNS is known to result in characteristic evoked potentials
when measured with EEG that match evoked potentials produced by implanted vagal nerve
stimulators [18]. Collectively, transcutaneous cervical nVNS results in vagal activation that
affects pain transmission and experience.
Pain autonomic responses and vagus nerve stimulation
Pain is a multimodal experience represented by a broad network of cortical and subcortical
structures, including the primary (SI) and secondary somatosensory (SII) cortices, bilateral
insular cortex (IC), anterior cingulate cortex (ACC), prefrontal cortex (PFC), thalamus, and
brainstem nuclei [19, 20]. Noxious thermal (painful) stimulation activates a sympathetic
response, as measured by an increase in galvanic skin response (GSR); [21–23], with a dose
response relationship to increasing thermal stimulus magnitude [24]. Prior work has identified
pain-mediated increased activation of the IC, amygdala, ACC, and PFC that correlates with
pain-evoked sympathetic activity (i.e. GSR), and together offer a baseline construct for the
neural basis of this autonomic pain dimension [25–29]. In the present study, we used func-
tional magnetic resonance imaging (fMRI) and primary physiological outcomes (GSR) to test
the hypothesis that nVNS may alter typical cortical and subcortical neural and physiological
autonomic responses to aversive noxious thermal stimuli more than to sham treatment. Prior
literature supports antinociceptive effects of vagal nerve stimulation in preclinical pain models
[30–35]. The antinociceptive effects of VNS are postulated to depend on afferent signaling to
the nucleus tractus solitarius (NTS), nucleus raphe magnus (NRM), and locus coeruleus (LC)
[32]. Based on this work, it has been proposed that vagal afferent inputs to NTS, NRM, and LC
result in a summative signal (including activation of descending noradrenergic, serotonergic,
and spinal opiodergic tracts) that inhibits dorsal horn neurons [34] [32] [35]. Adding to pre-
clinical work, multiple translational clinical studies also show similar antinociceptive effects of
acute [10, 36–39] and chronic VNS [40].
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and neural effects of nVNS measured with MEG.
These prior studies do not overlap with this study
and Electrocore had no part in this study funding or
design. This does not alter our adherence to PLOS
ONE policies on sharing data and materials.
Recent fMRI studies have revealed that nVNS affects brain areas important in pain process-
ing (e.g. the medial thalamus, dorsal ACC, IC, and PFC; [41–44], thus highlighting a potential
supraspinal vagal influence on pain perception. Only a single small pilot study (n = 20) has
evaluated the neural effects of transcutaneous VNS using auricular “Arnold’s nerve” stimula-
tion on experimental pain [37]. The results did not show a difference between groups, but a
post-hoc analysis of “responders”, i.e. subjects (n = 12) with increased pain threshold post-
nVNS, showed decreased activation during the application of pain stimuli in the left dorsopos-
terior insula, ACC, ventromedial PFC, caudate nucleus, and hypothalamus [37]. Notably, this
study performed continuous transcutaneous auricular VNS during the noxious thermal chal-
lenge, possibly confounding the results as emerging literature shows pronociceptive effects
during actual VNS, while the antinociceptive effects occur post-VNS [45, 46]. Taken together,
the evidence accumulated to date suggests that VNS alters clinical pain perception, but that
VNS must be carefully timed to produce antinociceptive effects.
Study objectives
The objective of this study was to gain a richer understanding of post-nVNS effects on sensory
discriminative neurocircuits, affective pain neurocircuits, and the peripheral autonomic
response to noxious thermal stimuli. Our goal was to determine the extent of post-nVNS neu-
ral effects on pain-related brain activation and autonomic tone. Taken together, this knowl-
edge could guide and improve the efficacious use of nVNS in pain-disease states.
Materials and methods
Participants
Thirty male and female subjects (age range, 18–54) were recruited through the Altman Clinical
and Translation Research Institute at the University of California, San Diego Health System.
Screening, exclusion, and inclusion criteria are found in Supplementary Information (S1 File).
All participants were right-handed and provided written, informed consent to participate in
the study. The Institutional Review Board at the University of California, San Diego Health
Systems approved this study (UCSD IRB project # 150202).
Intervention
Subjects were randomized to receive either nVNS (n = 15) or sham (n = 15) treatment (Fig
1A). A pair of nonferromagnetic stainless-steel surface electrodes (1-cm diameter) were placed
on the subject and secured with an adjustable Velcro strap collar. The 2 devices were identical
in appearance and subjects were blinded to specific intervention. Application of the device was
made to either the right anterior cervical area (overlying the carotid artery) for active nVNS,
or the right lateral cervical area (posterior to sternocleidomastoid) for the sham treatment.
Surface electrodes were connected to the battery-powered stimulation unit by a 6-m shielded,
grounded cable. Both the sham and nVNS devices delivered 1-ms duration bursts of 5 sinusoi-
dal wave pulses at 5000 Hz with a repetition rate of 25 Hz, and a continuous train duration of 2
minutes. In both the nVNS and sham treatments, a computational fixed, initial 30-second
ramp-up period was followed by 90 seconds of peak stimulation. In the nVNS treatment, the
voltage was increased to 24 V, whereas in the sham stimulation it was increased to 4.5 V. With
sham stimulation, subjects generally experience greater discomfort (because of stimulation of
neck muscles), with maximal tolerable amplitude typically only 2–8 V[44, 47]. Therefore, we
employed a maximum sham voltage of 4.5 V to the far lateral neck position [44, 47]. Prior
work suggests that use of the far lateral neck position with low voltage does not result in
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stimulation of the vagus nerve[44, 47]. Mourdoukoutas and colleague’s [11], recent work
shows (with finite element modeling) that active 20 V nVNS positioned directly over the
carotid artery results in electric field penetrance that activates the vagus nerve. Based on this
modeling we chose the maximum setting of 24 V known to activate the vagus nerve in the cer-
vical neck. Both nVNS and sham stimulation were carried out 9.5 minutes prior to the noxious
thermal stimulus paradigm (Fig 1B).
Thermal stimulus task
The thermal heat threshold and thermal heat tolerance were obtained prior to the MRI scan, as
previously described [48] (S1 File). During the MRI scan, noxious thermal stimulation up to a
Fig 1. Noninvasive vagus nerve stimulation study design. (a) Subjects were screened and randomized to either the
sham treatment or nVNS group. Sham stimulation was carried out posteriolateral to the sternocleidomastoid. In the
nVNS group, stimulation occurred anteromedial to the sternocleidomastoid and lateral to the trachea. In both the
nVNS and sham treatments, a computational fixed, initial 30-second ramp-up period was followed by 90 seconds of
peak stimulation. (b) Subjects were allowed to rest for 5 minutes before undergoing 2 minutes of nVNS (electrodes
placed over carotid) or sham stimulation (electrodes placed far lateral to the sternocleidomastoid). Subjects then rested
for an additional 5 minutes. Nine and a half minutes after either nVNS or sham stimulation, 5 successive noxious
thermal stimuli were applied in bouts of 5 seconds each, up to 49.8˚C. Each heat stimulus began 110 seconds after the
start of the previous one. fMRI, and GSR acquisition were taken 9.5 to 16.8 minutes after nVNS or sham treatment.
https://doi.org/10.1371/journal.pone.0201212.g001
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temperature of 49.8˚C was applied for 5 seconds via a fMRI-compatible thermode (probe size
3 x 3 cm; TSA-II, NeuroSensory Analyzer, MEDOC Advanced Medical Systems, Rimat Yishai,
Israel) attached via Velcro strap, to the left lower extremity (left anteromedial lower leg, ante-
rior to the medial gastrocnemius) in all participants. Five noxious thermal stimuli were succes-
sively applied for 5 seconds each, with a 105-second interval between each application. The
total duration of the task was 9 minutes and 15 seconds (Fig 1B). To tabulate the subjective
pain report, we used the numerical pain rating scale (NPRS), a validated pain-intensity score,
with a test-retest reliability of 0.71 to 0.99 that is highly correlated with the numerical pain rat-
ing scale and McGill Pain Questionnaire [49]. Ten seconds after each noxious thermal stimu-
lus ended(noxious thermal stimulus application from 1.5–6.5 sec), subjects visualized a
projector screen that displayed NPRS, at which point they were asked to rate their pain inten-
sity) numbered 0 to 10 (where 0 = no pain, and 10 = most intense pain possible). On the visual-
ized screen a cursor was slowly moved across the NPRS scale from 0-10(left to right over
approximately a 10 second time interval). Prior to scanning, the subject was instructed to raise
the right thumb when the cursor indicated the pain level experienced. A video camera visual-
ized the subject’s right thumb as it was raised (when the cursor passed under the specific num-
ber indicating their (i.e., #5/ 10) numerical pain rating). The subject’s pain report (number
when thumb was raised) was then recorded in the source document. Pain ratings were pro-
vided 10 seconds after termination of the pain stimulus and thus could be separated in the
slow event related design.
Galvanic skin response
We used the BioPac MP150 Psychophysiological Monitoring System (BioPac System Inc.,
Santa Barbara, CA) to measure psychophysiological reactivity at rest and during the noxious
thermal stimulus pain paradigm. The GSR was recorded using 2 electrodes positioned on the
volar pads of the distal phalanx of the middle and ring fingers of the right hand, and GSR was
sampled with a frequency of 1000 Hz. The mean GSR (in microsiemens) prior to the applica-
tion of each (#1-#5) noxious thermal heat stimulus (baseline GSR) was compared to the peak
GSR response after the application of noxious thermal stimulus for each trial (#1-#5). The
slope of GSR from baseline to peak was calculated (microsiemens/s). Additionally, the time (in
seconds) from baseline (prior to each noxious thermal stimulus) to the peak GSR response
(each post-noxious thermal stimulus) was measured and compared within and between
groups. The mean GSR response was defined as the average GSR (over 25 seconds) obtained
after the peak GSR was reached. Data analysis, including sample selection and artifact removal,
was carried out with AcqKnowledge software (version 4.42, BioPac System Inc.) and the R sta-
tistical programming language, version 3.4.3 [50].
Image acquisition
T2�-weighted echo-planar images were acquired on a 3T General Electric Discovery MR 750 [Mil-
waukee, WI; 360 volumes, TR = 1.5 s, TE = 30 ms, flip angle = 80˚, FOV 24 cm, 64 × 64 matrix,
3.75 × 3.75-mm in-plane resolution, 30 3.0 mm (1-mm gap) ascending interleaved axial slices]
using an 8-channel brain array coil. High-resolution T1-weighted FSPGR anatomical images (flip
angle = 8˚, 256 × 256 matrix, 172 1-mm sagittal slices, TR = 8.1 s, TE = 3.17 ms, 1 × 1-mm in-
plane resolution) were acquired to permit activation localization and spatial normalization.
Statistical analysis
Group demographics of GSR analyses. Group differences in questionnaires and demo-
graphic analyses were calculated with Mann-Whitney U tests. BIOPAC system measurements
nVNS alters neural and physiological responses to a noxious thermal challenge
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of GSR were incorporated into a mixed-model regression to evaluate within- and between-
group (nVNS vs sham) changes in GSR with each noxious thermal stimulus (from baseline, i.e.
prior to each (#1-#5) noxious thermal stimulus to after the noxious thermal stimulus has been
applied (#1-#5). The within- and between-group GSR post-thermal noxious stimulus mean
value (microsiemens), time to peak (seconds), and slope from the baseline GSR to the peak
(microsiemens/seconds) were compared. All statistical calculations were performed using the
R statistical programming language, version 3.4.3 [50].
MRI preprocessing. Structural and functional image processing and analysis were com-
pleted using analysis of functional neuroimages (AFNI) software [51] and R statistical pack-
ages. Echo planar images were slice-time and motion-corrected and aligned to high-resolution
anatomic images in AFNI. Volumes with >20% voxels marked as outliers using 3dToutcount
were censored and dropped from the analysis. For all group data points in the LME analyses
1.5% data censor were identified as outlier. Percentage Outlier voxels in the time series were
interpolated using 3dDespike. Functional data were aligned to standard space, resampled to
4-mm isotropic voxels, and smoothed with a Gaussian spatial filter (to 6 mm full width at half-
maximum). Hemodynamics of the pain experience were modeled using line interpolation
(3dDeconvolve/3dREMLfit modeled with TENT) for the span from the initiation of thermal
heat stimulus and the following 15 seconds as modeled by 5 regressors overtime. These regres-
sors were reconstructed to form a time series with 11 data points 1.5 seconds apart, which was
used in subsequent analysis.
Group differences in the time course of Blood Oxygen Level-Dependent (BOLD) responses
over the entire course of the pain experience were measured over the 5 noxious thermal appli-
cations. Time-course data were modeled using AFNI’s 3dDeconvolve TENT function. The
TENT function is a linear interpolation of the hemodynamic response function over time
described as piecewise linear splines. A group (nVNS or sham) × time, and (nVNS or sham) ×
time × GSR linear mixed-effects analysis (LME) using AFNI’s 3dLME was conducted to com-
pare time-course data from nVNS vs sham. Effects of interest included (group × time) and
(group × time × GSR) interactions, in which all were fixed effects without covariates. Group
and GSR were handled as between subject factors and time was a within subject factor. Multi-
voxel multiple comparisons were performed by Monte Carlo simulations (using AFNI
3dClustSim modeled with 3-perameter modeling noise) to reduce the potential for false posi-
tive results. A per-voxel threshold of p< .001, a cluster-wise threshold of p< .001, and a mini-
mum number of 14 voxels per cluster were used. The Montreal Neurological Institute (MNI)
atlas was used to identify clusters. Brainstem nuclei localizations in the group × time × GSR
LME were compared with graphical representations of brainstem nuclei from the Duvernoy
atlas [52] and compared to prior grey and white matter brainstem maps by Beissner and col-
leagues [53].
Results
Participant demographics and psychiatric assessments
The mean age between the nVNS (24.7 ± 3.7 years) and sham group (30.7 ± 10.3 year) was not
statistically different, as determined by a Mann-Whitney U test (p = .349). Subjects did not
report having elevated anxiety, depression, or posttraumatic stress disorder (PTSD), as mea-
sured by the Beck Anxiety Index (BAI), Beck Depression Inventory 2 (BDI-2), or the PTSD
Check List–Civilian version (PCL-C). Accordingly, no significant difference in mean scores
between groups was noted for these measures. There were no significant differences in gender
or race between the sham and nVNS groups. Two subjects failed the initial screen and were
excluded from the study; one had a preexisting arrhythmia disorder (Wolf-Parkinson-White
nVNS alters neural and physiological responses to a noxious thermal challenge
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syndrome) and the other had braces (Table 1). The total sample used for analysis (after exclu-
sion of the 2 subjects who failed screening) was 15 subjects in each of the VNS and sham
groups.
Pain and physiologic measures
Baseline pain measures. Subject responses to the baseline MPQ, measured at rest prior to
thermal threshold or tolerance testing, were not different between the groups (Table 2). Heat
thresholds, measured using the method of limits, were similar across groups (nVNS, 41.2˚-
C ± 2.8˚C; vs sham, 41.9˚C ± 2.0˚C; p = .935), as was heat tolerance, also, measured using the
method of limits,(nVNS, 49.0˚C ± 1.4˚C; vs sham, 48.71˚C ± 1.2˚C; p = 0.467; Table 2).
Pain reports during the fMRI task as measured by the NPRS
During the MRI task, 5 successive noxious thermal stimuli were administered based on ther-
mal tolerance measures, up to 49.8˚C (Fig 1B). The pain intensity score, measured as the mean
NPRS score reported during the noxious thermal stimulus paradigm, was similar between the
groups for each application of thermal stimulus (S1 Fig). Both groups reported NPRS scores
that were lower with the fifth thermal stimulus (decrease in NPRS, -0.678, ± 0.209; t = -3.241; p
= .002) compared with the first stimulus. We then compared the change in mean pain report
(NPRS) across each of the successive noxious thermal stimuli (T1-T5) between groups. In con-
trast to the nVNS group, subjects who underwent sham stimulation showed an increase in
NPRS with each of the successive noxious thermal stimuli from the second to the fourth
(T2-T4) (this change in pain score for each of the successive noxious thermal stimuli (T2-T4)
was calculated as a slope, i.e. sham slope; 0.150 ± 0.122) vs the decrease in NPRS with each of
the successive noxious thermal stimuli observed for nVNS (T2-4), (nVNS slope;
-0.233 ± 0.122; p = .0301) (S1 Fig). One subject in the sham group was unable to complete the
fifth 5-second noxious thermal stimulus due to discomfort. No other adverse events occurred
during the study.
Table 1. Subject demographics and psychiatric measures.
Sham (n = 15) nVNS (n = 15) Significance
Mean (min, max) [%] Mean (min, max) [%] p
Age (years) 27.0 (18.0, 54.0) 25.0 (18.0, 31.0) 0.349a
Sex 8M:7F [53%: 47%] 11M:4F [73%: 27%] 0.256 b
Race 0.460 a
Asian 5 [33%] 7 [46%]
Black 1 [7%] 0 [0%]
White 9 [60%] 7 [46%]
Other 0 [0%] 1 [7%]
Excluded 0 [0%] 2 [14%]
BAI 1.0 (0.0, 12.0) 1.0 (0.0, 13.0) 0.577 a
BDI-2 1.0 (0.0, 14.0) 2.0 (0.0, 17.0) 0.538 a
PCL-C 18.3 (17.0, 28.0) 18.3 (17.0, 28.0) 0.469 a
BAI = Beck Anxiety Inventory; BDI-2 = Beck Depression Inventory 2; PCL-C = Posttraumatic Stress Disorder Check
List–Civilian version.
a = Mann Whitney U statistical test.
b = Fishers exact test.
https://doi.org/10.1371/journal.pone.0201212.t001
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Galvanic skin response
The GSR was recorded with each noxious thermal stimulus. The time from the onset of the
each of noxious thermal stimuli to the peak GSR was measured in seconds. Mixed-model
regression analyses conducted across all noxious thermal stimuli (T1-5) and between groups
(nVNS vs sham) showed a significantly shorter time to peak in the nVNS group (p = .020; Fig
2A). Post-hoc comparisons between groups (with a 2-sample t test) revealed that subjects who
underwent nVNS had a shorter time to peak GSR compared with sham subjects during the
application of noxious thermal stimuli T1 and T2 (p< .05). Similar trends also approached
significance for T3 and T4 (p< .09; Fig 2A; S1 Table). We then measured the GSR slope (in
microsiemens) from the baseline GSR (prior to the application of each noxious thermal stimu-
lus) to the peak GSR (accompanying each noxious thermal stimulus) and compared how this
slope changed with each of the noxious thermal stimuli (T1-5). This GSR slope decreased
equally in both groups for T1 to T3 (Fig 2B). But in contrast to the nVNS group, which had an
average decrease in slope (-0.0461 microsiemens/second) for T3 to T5, the sham group showed
an increase in the average slope to peak GSR from T3 to T5 (0.049 microsiemens/seconds),
with a significant between-group difference observed (group x time interaction, -0.09508; p =
.0412; Fig 2B).
Within-group analysis conducted using a Mann-Whitney U test showed that the mean
GSR (measured for each of the successive noxious thermal stimuli) was successively lower in
the sham group after the application of the noxious thermal stimulus for T1, compared with
T4 and T5 (p< .05); T2 vs T3 (p< .05), T4, and T5, (p< .001); T3 vs T4 and T5 (p< .001);
and T4 vs T5 (p< .001; S2 Table). In the nVNS group, the mean GSR was successively reduced
after the application of the noxious thermal stimulus for T1 vs T3 (p = .016), T1 vs T4, and T5
(p< .005); T2 vs T3, T4, T5, (p< .001); and T3 vs T4 and T5 (p< .001; S3 Table).
Imaging results
Group differences during the application of thermal stimuli. During the application of
a noxious thermal stimulus, 21 regions met cluster thresholds in group × time LME analyses
(i.e., nVNS vs sham × time). Examination of this interaction indicated that regions in the left
insula, right cerebellum/declive, and right cuneus had large clusters of greater activation
(sham> nVNS). Additional regions important in the processing of thermal stimuli included
the left somatosensory cortex, bilateral mediodorsal thalamus, right dorsal anterior cingulate
gyrus, left supramarginal gyrus, and right medial frontal gyrus (orbitofrontal cortex [OFC];
Table 3). A TENT function analysis showed significantly greater activation during the
Table 2. Baseline pain measures.
Sham (n = 15) nVNS (n = 15) Mann-Whitney U
Mean (min, max)
[%]
Mean (min, max) [%] p
Adverse eventsa 1 [7%] 0 [0%]
MPQ 0.0 (0.0, 11.0) 5.0 (0.0, 59.0) 0.096
Heat threshold (˚C) 42.2 (39.1, 46.0 42.4 (34.0, 48.2) 0.935
Heat tolerance (˚C) 48.7 (47.1, 50.0) 49.3 (44.7, 50.6) 0.467
MPQ = McGill Pain Questionnaire.
aUnable to continue heat pain trial.
https://doi.org/10.1371/journal.pone.0201212.t002
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application of noxious thermal heat stimuli in the sham group in the SI (Fig 3A and Fig 3B),
SII (Fig 3C–3E), left dorsoposterior insula (Fig 3F and Fig 3G), and bilateral mediodorsal thal-
amus, as well as in the dorsal anterior cingulate (area 24; Fig 3H and 3J), and right medial fron-
tal gyrus (OFC; Fig 3K and Fig 3L).
Fig 2. nVNS vs sham autonomic measures of sympathetic tone galvanic skin response (GSR) with noxious
thermal challenge. (A) The time to peak galvanic skin response (GSR) measured in seconds after the application of
each of the noxious thermal stimuli was significantly reduced in the nVNS group for noxious thermal stimuli 1 and 2
(T1 and T2) (��p< .05) compared with the sham group, and approached significance for T3 and T4 (δp< .09). Mixed-
model regression showed that the combined (T1-T5) time to peak GSR in the nVNS group was significantly shorter
compared with the sham group (p< .02). (B) The GSR slope (in microsiemens) from the baseline GSR (prior to the
application of each noxious thermal stimulus) to the peak GSR (accompanying each noxious thermal stimulus) was
measured in each group. The slope from the baseline GSR to the peak response decreased in both groups with each
successively applied noxious thermal stimulus from T1 to T3. However, whereas the nVNS group showed a negative
average slope to peak GSR of -0.0461 from T3 to T5, the sham group showed a positive average slope to peak GSR of
0.049 from T3 to T5. The between-group difference (group x time interaction = -0.09508) for T3 to T5 was significant
at �p< .05. Red circles = nVNS group. Blue circles = sham group.
https://doi.org/10.1371/journal.pone.0201212.g002
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Imaging results with LME analysis
To better understand the relationships between neural and autonomic measures during ther-
mal stimuli, the GSR mean, measured from the peak after thermal stimulus for 15 seconds,
was incorporated into a group (nVNS vs sham) × linear time x GSR LME analysis using
AFNI’s 3dLME to compare time-course data from the nVNS and sham groups. The
group × time × GSR interaction showed that 3 regions met cluster thresholds; the postcentral
gyrus/somatosensory cortex (Fig 4A and Fig 4B), cerebellum/medullary brainstem (Fig 4C
and Fig 4D), and left occipital gyrus (Table 4). At the medullary level (i.e., level of the olive
from the lower pons, spanning to the lower medulla) multiple afferent fibers enter the brain-
stem, including vagus, glossopharyngeal, hypoglossal, and accessory nerves that synapse on
multiple brainstem nuclei (i.e., nucleus ambiguous (NAmb), dorsal motor nucleus of the vagus
nerve (DMNX) and nucleus tractus solitarius (NTS)). Other brainstem nuclei important for
pain processing (i.e., the rostral ventromedial medulla (RVM), rostral ventrolateral medulla
(RVLM), and nucleus reticularis (Rt)) are also found at this level. Brainstem nuclei localiza-
tions were compared with graphical representations of brainstem nuclei from the Duvernoy
atlas [52] and compared with prior grey and white matter brainstem maps by Biessner and col-
leagues [53]. Subjects in the sham and nVNS groups were separated by median into high and
low mean GSR categories, and the group × time × GSR interaction in the areas corresponding
to the above nuclei (within medulla/brainstem) were examined. During the application of nox-
ious thermal stimuli, subjects who underwent sham treatment and showed a high GSR
Table 3. Cluster results for group × time analysis of noxious thermal stimuli.
Voxels x y z Within BA t-test p-value
261 19 -63 -24 Right Cerebellum 3.976308 0.0004
131 -43 -36 28 Left Insula, Left Secondary Somatosensory 13 4.032758 0.0004
Cortex (SII), Left Dorsoposterior Insula
130 25 -80 8 Right Cuneus 17 3.994926 0.0004
88 1 -31 66 Bilateral Primary Somatosensory Cortex (SI) 3a 3.899217 0.0006
56 -18 -72 -24 Left Cerebellum 18 3.695176 0.0009
49 2 -21 -3 Bilateral Mediodorsal Thalamus 4.020902 0.0004
35 1 -31 36 Right Cingulate Gyrus 31 3.785605 0.0007
33 32 42 -12 Right Orbitofrontal Cortex 47 4.373772 0.0002
33 -21 -87 2 Left Lingual Gyrus 17 3.664152 0.001
26 7 8 44 Right Dorsal Anterior Cingulate Gyrus 24 4.024239 0.0004
25 3 -78 48 Right Precuneus 7 3.816214 0.0007
23 -40 -44 8 Left Superior Temporal Gyrus 41 4.816714 <0.0001
23 -19 -48 61 Left Precuneus 5 3.791053 0.0007
21 -36 -70 -31 Left Cerebellum 4.120962 0.0003
21 -21 -38 12 Left Caudate 48 3.740923 0.0008
20 -23 -82 31 Left Precuneus 19 3.751421 0.0008
17 -41 -16 44 Left Precentral Gyrus 4 3.636735 0.001
16 -21 -31 -2 Left Parahippocampal Gyrus 36 3.643388 0.001
16 -18 -1 15 Left Caudate 48 3.966382 0.0005
16 50 -26 22 Right Insula, Right Inferior Parietal Lobule 13 3.732593 0.0009
Right Secondary Somatosensory (SII)
16 -17 -48 24 Left Cingulate Gyrus 31 4.035837 0.0004
BA = Broadmann’s Area
https://doi.org/10.1371/journal.pone.0201212.t003
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demonstrated greater activity in the medulla/brainstem, compared with other groups (Fig 4C
and Fig 4D).
4. Discussion
The effects of VNS on the central and peripheral neural circuits involved in pain and auto-
nomic physiology are not well elucidated. In this study nVNS treatment (when compared to
Fig 3. Group differences in the time course of Blood Oxygen Level-Dependent (BOLD) responses over the
entire course of the pain experience. Imaging of (a) the bilateral somatosensory cortex (SI), and (c) SII, (f) left
dorsoposterior insula, (h) bilateral mediodorsal thalamus and dorsal anterior cingulate (area 24), and (k) right media
frontal gyrus (orbitofrontal cortex; OFC). Differential hemodynamic response curves during the application of noxious
thermal stimuli 10 to 15 minutes following VNS (turquoise) and sham treatments (pink) were generated with a
group × time, linear mixed-effects analysis showed that (b) subjects in the sham group had greater activity in the
bilateral postcentral gyrus (SI; p = .0006). Treatment with nVNS significantly decreased the response of the postcentral
gyrus during and after the application of noxious thermal stimuli (5 seconds each), up to 12 seconds after cessation of
the painful stimulus. Subjects in the sham group had greater activity in the bilateral SII (d, e) (mean and SE shown)
(right p = .0009, left p = .0009)]. Subjects in the sham group had greater activity in the left posterior insula (g) (mean
and SE shown; p = .0004), during and after the application of noxious thermal stimuli (5 seconds each). This result
demonstrates blunting of the usual temporal dynamic response of the insula (as seen in the sham group) that is most
evident during and up to 10 seconds after cessation of the painful stimulus. The sham group showed significantly
greater activity in the medial thalamus and anterior cingulate (area 24) (i, j) (mean and SE shown; mediodorsal
thalamus p = .0004, area 24 p = .0004), during and after the application of noxious thermal stimuli (5 seconds each).
Subjects in the nVNS group had significantly decreased activity in right middle frontal gyrus (l), overlapping with the
medial and lateral OFC (mean and SE shown; p = .0002) followed by an increase in OFC response (greater than sham)
that was most evident at the 10 to 15 second mark.
https://doi.org/10.1371/journal.pone.0201212.g003
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sham) resulted in reduced responses in highly relevant pain-processing nodes. There was a
significant alteration of autonomic tone, as determined by a decrease in sympathetic activity
(measured with GSR) and attenuated activity in brainstem nuclei known to contribute to
pain-mediated autonomic responses. These results provide preliminary evidence of significant
nVNS modulation of central and peripheral autonomic neural circuits relevant to pain
perception.
Fig 4. Neural and autonomic measures taken during the application of thermal stimuli (mean GSR, measured
from the peak after the application of the thermal stimulus for 15 seconds). Group (nVNS vs sham) × linear time x
GSR linear mixed-effects analysis. (A) Compared with subjects in the nVNS group, subjects who underwent sham
treatment showed significantly greater activity in the bilateral somatosensory cortex. (B) Differential hemodynamics of
pain following nVNS (turquoise) and sham (pink) treatment. (SI; mean and SE show; p = .0002). (C) Cerebellum/
medullary brain stem measures taken during the application of thermal stimuli show (D). To assist in visual
representation of this region of interest, the sham and nVNS groups were separated into high and low mean GSRs
(using a group median of 16 microsiemens; the high group included 5 subjects who received sham treatment and 7
subjects who received nVNS treatment). (D) Only the high-GSR sham group (pink shade with blue line) demonstrated
greater activity in the medulla/brain stem with the application of noxious thermal stimuli. At this medullary level (i.e.
the level of the olive from the lower pons, spanning to the lower medulla) multiple afferent fibers enter the brainstem,
including the vagus, glossopharyngeal, hypoglossal, and accessory nerves, that synapse on multiple brainstem nuclei
[i.e. the nucleus tractus solitarius (NTS), nucleus ambiguous (NAmb), and dorsal motor nucleus of the vagus nerve
(DMNX)]. Other brainstem nuclei important for nociception [i.e. the rostral ventrolateral medulla (RVLM), rostral
ventromedial medulla (RVM), and nucleus reticularis (Rt)] are also found at this level.
https://doi.org/10.1371/journal.pone.0201212.g004
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Post-Non-invasive vagus nerve stimulation with noxious thermal stimuli;
neural effects on bilateral somatosensory cortex 1 (SI) and somatosensory
sortex 2(SII) (i.e., Lateral Pain Pathway)
Compared with subjects in the sham group, group × time LME analysis showed that subjects
in the nVNS group had decreased neural activation of SI and SII, the medial dorsal thalamus,
ACC, IC, and OFC—all brain regions associated with the processing of painful stimuli. Meta-
analysis of human data from fMRI, EEG, magnetoencephalography (MEG), and positron
emission tomography (PET) studies has shown that the commonest regions found to be active
during an acute pain experience [19] are the SI and SII, thalamus, ACC, IC, and PFC, (compa-
rable to areas that show decreased activity with nVNS in this study). Analysis of the group x
time interaction showed a decrease in responses of the bilateral SI and SII somatosensory cor-
tex, suggesting that nVNS mediates this signaling during the application of a thermal stimulus.
These nVNS-mediated response changes in the SI somatosensory cortex strip match bilateral
somatotopy to the lower leg, consistent with the placement of the Peltier heat probe. It is gen-
erally believed that somatosensory stimuli are processed primarily or preferentially by the
hemisphere that is contralateral to the point of stimulation. However, evidence from clinical
studies in patients with brain lesions, and from brain-imaging studies of noxious painful sti-
muli have called this theory into question [54]. Well-established brain regions that show bilat-
eral activation upon the application of painful stimuli include the ACC, PFC, SII, insula,
thalamus, and inferior parietal lobe [55–60]; and, in some instances, SI [55, 61–63]. It is likely
that nVNS-mediated bilateral decreases in SI represent modulation of cortical context and or
anticipatory neurocircuits. We postulate that the observed effects of nVNS on bilateral pain-
processing pathways may represent bilateral nVNS afferent signaling effects; possible afferent
to bilateral efferent effects on the thermal (and possibly nociceptive) signaling pathways of the
spinal cord; or direct disruption of normal bilateral thermal and nociceptive afferent neural fir-
ing patterns that either independently or collectively change the temporal dynamics of pain
processing.
Post-Non-invasive vagus nerve stimulation with thermal stimuli; neural
effects on left dorsoposterior insula
In addition to nVNS-mediated bilateral SI and SII responses, our analysis showed a unilateral
decrease in the left dorsoposterior insula. The dorsoposterior insula exhibits an anterior-to-
posterior somatotopic organization in response to innocuous or noxious/painful stimuli as
measured with fMRI [64–68]. Various painful stimuli, including hypertonic saline injection
[65], thermal stimuli [66], and laser stimuli [69], have consistently reproduced this anteropos-
terior somatotopy within the dorsoposterior insula; specifically, rostral targets (head/neck)
localizing more anteriorly whereas caudal targets (leg) localizing posteriorly [70].
Table 4. Cluster results of group × time × GSR LME analysis.
Voxels x y z Within BA t test p value
414 3 -49 -54 Bilateral Medulla Cerebellum 5.398 <0.0001
25 4 -44 63 Bilateral Primary Somatosensory Cortex (SI) 3b 4.200 0.0002
15 -26 -92 -13 Left Lingual Gyrus 18 4.158 0.0003
GSR = galvanic skin response; LME = linear mixed effects.
BA = Broadmann’s Area
https://doi.org/10.1371/journal.pone.0201212.t004
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Dorsoposterior insular stroke results in discrete thermoanesthesia and analgesia that equiva-
lently mapped anteroposterior somatotopy, further supporting the idea that the dorsoposterior
IC plays a critical role in the pain experience [71–75]. Neuroanatomical data have demon-
strated that the lamina I spino-thalamo-cortical pathway convey both nociceptive and intero-
ceptive information mapped to the viscerosensory cortex in the posterior and mid-insular
cortex, which is then represented in the anterior insula [76–78]. Surgically implanted vagal
nerve stimulators (FDA-approved for treatment of resistant depression and epilepsy) consis-
tently [79–84] modulate insular cortex activity, thus pointing to the insula as a possible neuro-
modulatory target for nVNS. Moreover, while insular activity is known to increase during
acute VNS [79–81], recent work has shown a resultant decrease in insular activity at 10 to 15
minutes post-nVNS [43]. In our cohort, there was a significant left dorsoposterior insula
decrease in activity 10 to 17 minutes post-VNS that further support the temporally dependent
dose-response effects of VNS.
As a whole, the observed changes in the response to pain in the SI, SII, and left dorsoposter-
ior insula with nVNS infer possible nVNS-mediated changes in neuronal firing patterns, either
through direct brainstem effects, afferent cortical, or afferent cortical-to-efferent brainstem/
spinal cord effects on nociceptive signaling.
Post-Non-invasive vagus nerve stimulation with thermal stimuli; neural
effects on bilateral mediodorsal thalamus and anterior cingulate cortex
(area 24) (i.e. medial pain pathway)
Beside lateral thalamic nuclei projections (i.e., ventroposterior-lateral and ventroposterior-
medial thalamic nuclei) to the SI and SII, known to relate the sensory-discriminative aspects of
pain spinal pathways to limbic structures, the medial thalamic nuclei provide inputs to emo-
tion-related brain areas, including the insula, ACC, amygdala, PFC, and other regions impor-
tant in processing the affective-motivational dimension of the unpleasant pain experience
[85]. In our study, the nVNS group showed a decreased response in the bilateral mediodorsal
thalamus and dorsal ACC (Brodmann area 24) during the application of thermal stimulation,
(with the group x time interaction). Prior clinical work shows that the mediodorsal thalamus is
important in antinociceptive regulation [86], the processing of emotions [87], affective pain
processing (pain unpleasantness) [66, 88, 89] [90–92],[87], thought to occur through medio-
dorsal thalamic connections with dorsal ACC (area 24). In an illustrative case study, a patient
with a somatosensory cortex stroke that spared the dorsal ACC (area 24) and thalamus
(including mediodorsal thalamus) reported usual contralateral limb analgesia to painful sti-
muli, but the patient continued to report an “unpleasant” feeling with the application of pain-
ful stimulus, suggesting in vivo separation of the affective and sensory discriminative pain
pathways [89]. We observed mediodorsal thalamus and dorsal anterior cingulate deactivation
in the nVNS group, which likely indicates a key mechanism of the effect of nVNS on the
medial affective pain pathway, in agreement with previous studies [86, 93, 94]. Based on this
remarkable (but preliminary) finding in a future study we will measure nVNS effects on affec-
tive pain (i.e. pain unpleasantness).
Post-Non-invasive vagus nerve stimulation with thermal stimuli; neural
effects on right orbitofrontal cortex
In addition to the medial dorsal thalamic connections to ACC, there are known medial tha-
lamic projections to the PFC, ventromedial-prefrontal, and orbitofrontal (OFC) cortices [95,
96]. The group × time analysis in the current study showed decreases in the right OFC
response, suggesting that nVNS mediates this signaling during nociceptive stimulation (Fig 3K
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and Fig 3L). Prior clinical work has also demonstrated involvement of the prefrontal and fron-
tal cortical regions in reflecting the emotional, cognitive, and interoceptive components of
pain conditions, negative emotions, response conflicts, decision-making, and appraisal of
unfavorable personal outcomes [97, 98]. Multiple pain-imaging studies have found that the
frontal cortical regions are critical for controlling functional interactions among key brain loci
that produce changes in the perceptual correlates of pain, independent of changes in nocicep-
tive inputs [66, 99, 100]. Manipulating the cognitive aspects of pain, such as reappraisal, con-
trol, and coping, produce neural changes in the brain thought to be important in top-down
processing. The lateral OFC expresses a contextual modulation of response that is widely
implicated in emotional regulation and decision-making behaviors [101, 102], and it has been
postulated that the valuation of pain is context-sensitive, as classified by the OFC [103]. Activ-
ity in the ventromedial cortex and the OFC has repeatedly been shown to be modulated by
acute [80, 104–107] and chronic VNS [80, 104, 108]. In this cohort, we showed initial decrease
in OFC activation during nociceptive thermal stimulation followed by an increase in OFC
response (greater than sham) that was most evident at the post-thermal stimulation 10 to 15
second mark. This interesting finding suggests a decrease in the OFC affective appraisal of
pain (0–6 seconds) followed by a subsequent late hemodynamic response increase that may
reflect a resultant increase in pain-coping behavior. The observed nVNS-mediated decrease in
the response of the OFC during the application of maximal noxious thermal stimulation is
consistent with the results of prior VNS-treatment imaging studies, and suggests that the effect
of nVNS on the OFC likely plays a role in the processing of painful and aversive stimuli.
Non-invasive vagus nerve stimulation; combined neural effects and
physiological measures (GSR)
The group × time × GSR analysis highlighted differential interactions among nVNS, GSR, and
the temporal dynamic of pain responses in the cerebellum, medulla/brainstem nuclei, bilateral
SI, and a right occipital gyrus cluster. In addition to cortical nodes, the mid and lower medul-
lary brainstem have been shown to be important sites that demonstrate an interaction between
sympathetic output and pain, with decreases in sympathetic output (as measured with cardiac
vagal tone) shown to correlate with brain stem nuclei including: 1) RVLM, 2) Rt, 3) NAmb, 4)
DMNX and 5) the RVM, (all found superior to the obex at the level of the olive spanning to
lower medulla) [109]. In this study, medulla/brainstem clusters from sham and nVNS groups
were separated into high and low mean GSRs. Only the sham treatment group showed a high
GSR, demonstrated by greater activity in the medulla/brainstem, compared with other groups
(sham low, nVNS high, nVNS low). At the level of the medulla, where this interaction is found
(i.e., superior to the obex at the level of the olive from the lower pons, spanning to the lower
medulla) multiple afferent fibers enter the brainstem, including the vagus nerve, and the glos-
sopharyngeal, hypoglossal, and accessory nerves, as well as multiple nuclei and tracts (i.e.,
DMNX, NTS, NAmb, RVM, RVLM, and the Rt). In particular, the Rt is proposed to be pri-
marily a pronociceptive center that integrates multiple excitatory and inhibitory functions
important in nociceptive processing [110]. The premotor nuclei (i.e., NAmB and DMNX) are
critical in autonomic response patterns evoked by physiological and sensory stimuli [111] that
culminate in efferent parasympathetic outflow and play a crucial role in parasympathetic
reflexes, accepting input from the NTS that is the principal nucleus for incoming afferent sig-
nals from the vagus nerve [112]. The RVM is intricately involved in areas of endogenous pain
modulation in the brain, conveying descending pain modulatory influences from the PAG to
neurons located in the dorsal horn of the spinal cord. The ON and OFF cells of the RVM
increase or decrease activity during the application of painful stimuli, respectively [113], with
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notable effects on descending pain-inhibitory circuits [114]. In sum, decreased activity in the
medulla found in this study can be seen in reduced autonomic tone (reduced GSR in the lower
GSR sham group), or through vagal nerve stimulation (in both nVNS groups, regardless of
GSR (high or low)) suggesting that the default regulation of GSR can be decoupled through
nVNS. We postulate that, even with increased GSR output (high GSR in the nVNS group),
nVNS inhibits the response of the central nervous system to pain (in part) by blunting the
response in key nuclei in the medulla that relay autonomic responses. Support for the relation-
ship between the nVNS neural response and physiological response stems from altered auto-
nomic sympathetic output (i.e., time to peak GSR and decrease in GSR slope). Future study is
planned to examine this interaction in disease states such as Posttraumatic Stress Disorder or
Major Depressive Disorder where dysfunctional emotional regulation and dysregulated auto-
nomic output coincide.
Non-invasive vagus nerve stimulation; autonomic measures and pain
report
Time to peak GSR (i.e., time from GSR measured immediately prior to each 5 second noxious
thermal stimuli to peak post-noxious thermal stimuli) in the nVNS group was more rapid than
in the sham group, indicating changes in the temporal dynamics of pain processing and subse-
quent sympathetic output. The temporal dynamic of GSR during the application of a thermal
stimulus is an important component of autonomic responsivity [21–23], and the subsequent
emotional regulation of aversive stimuli [115, 116]. Loggia and colleagues demonstrated the
existence of a dose-response relationship between the magnitude of a thermal stimulus and the
time to peak GSR [24]. Specifically, their study showed that the greater the impact of a stressor
(increased thermal temperature), the greater the rise in GSR, thus resulting in a longer time to
peak response. In addition to the longer time to peak observed in the sham group, significant
differences between the nVNS and sham groups in the slope of the GSR rise from baseline
(prior to each noxious thermal stimuli to peak after noxious stimuli) for the latter thermal sti-
muli (T3-T5) were observed. In particular, the slope of the GSR response decreased across the
length of the task in the nVNS group, whereas the slope of the response in the sham group
increased. Taken together the longer time to peak and increase in GSR slope in the sham
group compared to the nVNS group further suggest nVNS alters sympathetic output, possibly
to due to the brainstem and cortical effects described.
We did not detect a statistically significant difference in subjective reports of pain for each
thermal stimulus with a near maximal noxious thermal stimulus (S1 Fig). However there was a
significant difference in the change in response between subjects who underwent nVNS vs
sham stimulation across thermal stimuli (T2-T4) in reports of pain, as measured by the NPRS.
The group that underwent sham stimulation showed a progressive increase in NPRS (across
thermal stimuli T2-4), whereas the nVNS group demonstrated a significant decrease in NPRS
(across thermal stimuli T2-4). To further characterize the effects of nVNS, additional work is
needed that carefully measures affective pain, such as unpleasantness and catastrophizing,
associated with the application of noxious thermal stimuli.
Non-invasive vagus nerve stimulation potential temporal dependent effects on brain &
pain. Henry and colleagues [79] first argued (2002), that neural effects which occur during
VNS are very different from those that occur after VNS, while others continue to confirm this
phenomenon [43, 44, 117]. In this study, we showed that subjects in the nVNS group had
nVNS-mediated activity decreases in the dorsoposterior insula, low medullary brainstem,
medial thalamic, and ACC compared with subjects in the sham group (occurring 10 to 17 min-
utes after nVNS treatment). Similar to our post-nVNS effects observed on the low medullary
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brainstem, Frangos and colleagues also show post-cervical transcutaneous VNS effects in this
time frame, (13–15 minutes after stimulation), in posterior insula, lower medullary brainstem
and medial thalamic/ACC deactivation at rest [44], that provide a convergence of preliminary
evidence supporting a temporal nVNS dose-response curve [44]. In line with the aforemen-
tioned post-VNS neural effects, emerging clinical literature also demonstrate post-VNS anti-
nociceptive effects [40, 118] while pronociceptive effects during VNS have also been reported
[45, 46]. Both prior literature and this study suggest that the temporally dependent neural
effects (i.e. during vs post-stimulation) of VNS may be critical to clinically relevant pro- or
anti-nociceptive effects of VNS treatment, and therefore should be taken into account in future
clinical study designs. Moreover, future studies are planned to determine the temporal dose
response curve on affective pain processing that may also be of clinical import to guide effica-
cious use of VNS for clinical comorbid pain and psychiatric syndromes.
Limitations
Our work has some important limitations. The study was carried out in healthy control sub-
jects. Because, as a pilot study, we involved only 15 subjects per group, the small sample size
may not adequately represent a larger population. Therefore, our results as described here
should be considered preliminary. However, the positive findings observed in this small cohort
of healthy control subjects were robust and significant, warranting further investigation of the
effects of cervical transcutaneous nVNS on the brain in a larger cohort of healthy control sub-
jects, and in subjects who may experience a greater magnitude of affective pain subtypes, that
may include Posttraumatic Stress Disorder or Major Depressive Disorder. Our study found
significant neural alterations in the temporal dynamics of noxious thermal-stimuli processing
known to be important in affective pain processing, and group differences in changes in the
subjective pain report across the thermal stimuli (T2-T4). But we did not detect a statistically
significant difference in subjective reports of pain for each thermal stimulus with a near maxi-
mal noxious thermal stimulus (S1 Fig). We chose a near maximal noxious thermal stimulus to
ensure clear autonomic responses (GSR). Our own work [48] as well as that of other studies
has described maximal noxious stimuli that result in maximal reports of pain and, therefore,
blunting of group differences in mean reports of pain (i.e. a ceiling effect on pain report) [119–
121] [122]. This phenomenon also could have occurred in this study. Future studies that mea-
sure affective pain (such as pain unpleasantness and catastrophizing) using maximal and sub-
maximal noxious thermal stimuli are now needed to further characterize the antinociceptive
effects of nVNS, as measured by reports of pain. While we correct for motion artifact at the
brainstem level with the (Group x time x GSR) interaction, this area can be artifact-prone due
to motion and decreased spatial resolution. Although others have shown a similar pain and
autonomic tone interaction at the same medullary brainstem level (Sclocco and colleagues
[109]) future study is planned in larger cohorts and with high spatial resolution multiband
imaging to confirm this interaction at this brainstem level.
Conclusion
We examined the neural effects of nVNS during a noxious thermal stimulus challenge, in the
context of autonomic responses. We demonstrated 3 major findings; first, nVNS activity not
only reduces peak responses to thermal stimuli in the SI, SII, medial thalamus, dorsal anterior
cingulate (area 24), dorsoposterior insula, and OFC, which are important nodes in sensory dis-
criminative pain, affective emotional pain, and interoception pathways, but also changes tem-
poral dynamic responses within these nodes. Second, nVNS alters autonomic responses to
noxious thermal stimuli, as measured by GSR, and therefore affects critical autonomic pain
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networks. Third, even with a higher GSR response being provoked by the application of nox-
ious thermal stimulus, nVNS decreased the central nervous system response by blunting the
usual reactions in key nuclei in the medulla that relay autonomic responses. These significant
findings may improve effectual nVNS that, if tuned with careful dose-response curves in
mind, could translate into efficacious targeted effects on pain and autonomic neural circuits.
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S1 Fig. nVNS versus sham numerical pain rating with maximal noxious thermal stimuli.
After either nVNS or sham stimulation, 5 successive noxious thermal stimuli were applied (up
to 49.8˚C) for 5 seconds each (T1-T5). Mean pain, as reported by subjects using the numerical
pain rating scale (NPRS) after each noxious thermal stimulus did not differ between the sham
and nVNS groups. Both groups had lower NPRS scores at T5 compared with T1 (NPRS
decreased by -0.678 ± 0.209; t = -3.241; p = .002). In contrast to findings for the nVNS group,
subjects who underwent sham stimulation had a positive slope in NPRS scores across thermal
stimuli (i.e. the change in NPRS score with successive noxious thermal stimuli T1-T5) for T2
to T4 that was significantly different (slope in the sham group, 0.150 ± 0.122; vs the slope in
the nVNS group, -0.233 ± 0.122; p = .0301) and also approached significance from T1 to T4
(sham group, 0.010 ± 0.847; vs nVNS group, -0.203 ± 0.847; p = .0785). Red circles = nVNS
group. Blue circles = sham group. �p< .05; δp< .08.
(DOCX)
S1 Table. Between-group comparisons for the time to peak and absolute mean GSR. The
nVNS group showed significant decreases in the time to peak GSR for T1 and T2. There was
no difference in GSR absolute mean change between groups for all time points examined.
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S2 Table. Within-group comparisons for the time to peak GSR and absolute mean GSR for
the sham stimulation group. In the sham group, the time to peak GSR increased from T1 to
T4 and T5. The mean GSR measured after the application of noxious thermal stimuli consis-
tently increased from T2 to T5 and from T1 to T4.
(DOCX)
S3 Table. Within-group comparisons for the time to peak GSR and absolute mean GSR for
the nVNS group. In the nVNS group, the time to peak GSR did not change between each suc-
cessively applied noxious thermal stimulus. The mean GSR measured after each noxious ther-
mal stimulus did not increase from T4 to T5, or from T1 to T2.
(DOCX)
S1 File. Inclusion and exclusion criteria. Heat tolerance and threshold measurements. Cor-
relations between autonomic tone and pain reports. This file contains information on inclu-
sion exclusion criteria, a description of heat tolerance and threshold measurements and finally
pertinent correlations between autonomic tone and pain reports.
(DOCX)
S1 Data Set. Demographic and pain data sets. This data set contains demographic informa-
tion and pain rating data sets.
(XLSX)
S2 Data Set. fMRI and gsr measures during thermal stimulus. This data set contains in MRI
scanner GSR measures in sham and nVNS groups during five thermal stimuli.
(XLSX)
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S3 Data Set. fMRI cluster data sets for all subjects GroupXTime. This data set contains clus-
ter results for group × time analysis of noxious thermal stimuli.
(CSV)
S4 Data Set. fMRI cluster data sets for all subjects GroupXTimeXGSR. This data set con-
tains cluster results for group × time x GSR analysis of noxious thermal stimuli.
(XLSX)
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